Oluseye O. Bolaji

Simple Reversed-Phase High Performance Liquid Chromatographic Estimation of the Antiretroviral Agent Efavirenz from Human Plasma

Benjamin U. Ebeshi, Oluseye O. Bolaji, Margaret Oluka, Vaikosen N. Edebi, Julius O. Soyinka & Anastasia Guantai · Journal of Pharmaceutical Research International · 2013

Aims: Sequel to the resurgence of TB co-infection in HIV/AIDS patients in sub-Saharan Africa, efavirenz has become an important component of the highly active antiretroviral treatment (HAART). The objective of this study therefore is to provide a simple reversed-phase high perfor...

Open access Research Article 10.9734/BJPR/2014/4123

Preparation and Physicochemical Evaluation of Lumefantrine-2-Hydroxypropyl-β-cyclodextrin Binary Systems

Adebanjo J. Adegbola, Ezekiel Omotoso, Olujide O. Olubiyi, Julius O. Soyinkaa, Oluseye O. Bolaji & Cyprian O. Onyeji · Journal of Pharmaceutical Research International · 2020

Lumefantrine contributes significant roles in artemisinin-based combination therapy for malaria treatment but associated with a limitation of poor aqueous solubility and low permeability. This study investigated lumefantrine-2-hydroxypropyl-β-cyclodextrin complex to improve its s...

Open access Research Article 10.9734/jpri/2020/v32i1330589